Free Trial

Global Medical REIT Inc. (NYSE:XRN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Global Medical REIT logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst consensus: Five brokerages give Global Medical REIT an average recommendation of "Moderate Buy" (2 holds, 2 buys, 1 strong buy) with an average 12‑month price target of $40.50.
  • Dividend announced: The company declared a monthly $0.25 dividend (ex‑dividend May 20), implying an 8.3% yield, though a dividend payout ratio of -333.33% indicates payouts exceed reported earnings.
  • Valuation and balance sheet highlights: Shares trade near $36.19 with a market cap of ~$479M, a negative P/E of -40.21 and a debt‑to‑equity ratio of 1.62, signaling profitability and leverage concerns despite ~57.5% institutional ownership.
  • MarketBeat previews the top five stocks to own by May 1st.

Shares of Global Medical REIT Inc. (NYSE:XRN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $40.50.

A number of research firms recently issued reports on XRN. Weiss Ratings raised shares of Global Medical REIT from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, January 21st. Wall Street Zen upgraded shares of Global Medical REIT from a "sell" rating to a "hold" rating in a report on Saturday, April 4th.

Get Our Latest Stock Report on Global Medical REIT

Global Medical REIT Stock Performance

NYSE XRN opened at $36.19 on Tuesday. The firm has a market cap of $478.73 million, a price-to-earnings ratio of -40.21 and a beta of 1.16. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.62. Global Medical REIT has a twelve month low of $29.05 and a twelve month high of $39.93. The business has a 50-day moving average price of $35.42 and a 200-day moving average price of $34.13.

Global Medical REIT Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, June 12th. Stockholders of record on Wednesday, May 20th will be issued a $0.25 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 8.3%. The ex-dividend date is Wednesday, May 20th. Global Medical REIT's dividend payout ratio (DPR) is currently -333.33%.

Institutional Trading of Global Medical REIT

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd grew its position in shares of Global Medical REIT by 1,001.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company's stock valued at $27,000 after purchasing an additional 721 shares during the period. Fifth Third Bancorp purchased a new stake in Global Medical REIT during the 3rd quarter worth approximately $35,000. New York State Teachers Retirement System purchased a new position in shares of Global Medical REIT in the third quarter valued at approximately $39,000. Tower Research Capital LLC TRC boosted its stake in shares of Global Medical REIT by 70.3% in the second quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company's stock worth $51,000 after acquiring an additional 3,046 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. purchased a new stake in shares of Global Medical REIT during the second quarter worth approximately $78,000. 57.52% of the stock is owned by institutional investors and hedge funds.

About Global Medical REIT

(Get Free Report)

Global Medical REIT NYSE: GMRE is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.

Featured Articles

Analyst Recommendations for Global Medical REIT (NYSE:XRN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Global Medical REIT Right Now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines